4//SEC Filing
Flynn Daniel Lee 4
Accession 0001209191-22-038425
CIK 0001654151other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:34 PM ET
Size
6.2 KB
Accession
0001209191-22-038425
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-06-16$10.75/sh−1,768$19,006→ 46,098 total
Holdings
- 230,435(indirect: By Trust)
Common Stock
- 91,020(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001713712
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:34 PM ET
- Size
- 6.2 KB